A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

Clinical trial NCT03969992 · COMPLETED

Trial details

NCT number: NCT03969992
Sponsor: Aerogen Pharma Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Distress Syndrome in Premature Infant

Start date: 2020-03-04
Primary completion: 2023-08-04
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.